Neuro-Inflammaging and Psychopathological Distress.
chronic inflammatory diseases
clinical psychology
inflammaging
neuroinflammation
pro-inflammatory cytokines
psychopathological disorders
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
31 Aug 2022
31 Aug 2022
Historique:
received:
14
07
2022
revised:
24
08
2022
accepted:
29
08
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
24
9
2022
Statut:
epublish
Résumé
Inflammaging is a low degree of chronic and systemic tissue inflammation associated with aging, and is intimately linked to pro-inflammatory mediators. These substances are involved in the pathogenesis of chronic inflammatory diseases and related psychopathological symptoms. When inflammation and aging affect the brain, we use the term neuro-inflammaging. In this review, we focused on the neuro-inflammatory process typical of advanced ages and the related psychopathological symptoms, with particular attention to understanding the immune-pathogenetic mechanisms involved and the potential use of immunomodulatory drugs in the control of clinical psychological signs. Inflammation and CNS were demonstrated being intimately linked in the neuro-inflammatory loop. IL-1, IL-6, TNF-a, COX and PGE are only partially responsible. BBB permeability and the consequent oxidative stress resulting from tissue damage make the rest. Some authors elaborated the "theory of cytokine-induced depression". Inflammation has a crucial role in the onset symptoms of psychopathological diseases as it is capable of altering the metabolism of biogenic monoamines involved in their pathogenesis. In recent years, NSAIDs as an adjunct therapy in the treatment of relevant psychopathological disorders associated with chronic inflammatory conditions demonstrated their efficacy. Additionally, novel molecules have been studied, such as adalimumab, infliximab, and etanercept showing antidepressant and anxiolytic promising results. However, we are only at the beginning of a new era characterized by the use of biological drugs for the treatment of inflammatory and autoimmune diseases, and this paper aims to stimulate future studies in such a direction.
Identifiants
pubmed: 36140234
pii: biomedicines10092133
doi: 10.3390/biomedicines10092133
pmc: PMC9495653
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Gerontol A Biol Sci Med Sci. 2003 Mar;58(3):232-7
pubmed: 12634289
Inflamm Res. 2021 Jan;70(1):29-49
pubmed: 33231704
Biol Psychiatry. 2010 Mar 1;67(5):446-57
pubmed: 20015486
Mech Ageing Dev. 2007 Jan;128(1):92-105
pubmed: 17116321
Sleep Med. 2018 Dec;52:188-195
pubmed: 30243610
Transl Psychiatry. 2016 May 31;6(5):e825
pubmed: 27244234
Mol Neurobiol. 2017 Dec;54(10):8071-8089
pubmed: 27889895
PeerJ. 2016 Apr 05;4:e1864
pubmed: 27069803
J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1:S4-9
pubmed: 24833586
Psychoneuroendocrinology. 2013 Sep;38(9):1803-13
pubmed: 23571152
J Gerontol A Biol Sci Med Sci. 2021 Jan 18;76(2):211-215
pubmed: 32585682
Semin Immunol. 2018 Dec;40:17-35
pubmed: 30287177
Psychol Med. 2018 Apr;48(6):961-973
pubmed: 28929992
Neuroscience. 2013 Aug 29;246:199-229
pubmed: 23644052
Front Psychiatry. 2019 May 31;10:375
pubmed: 31214060
Biomed Rep. 2017 Aug;7(2):188-192
pubmed: 28804633
Brain Behav Immun. 2015 Oct;49:206-15
pubmed: 26065825
Aging (Milano). 2000 Apr;12(2):77-84
pubmed: 10902049
Curr Alzheimer Res. 2017;14(4):412-425
pubmed: 27697064
Arch Immunol Ther Exp (Warsz). 2016 Apr;64(2):111-26
pubmed: 26658771
Biomedicines. 2022 Jul 20;10(7):
pubmed: 35885055
Int J Mol Sci. 2022 Jan 30;23(3):
pubmed: 35163538
JAMA Psychiatry. 2015 Jun;72(6):527-8
pubmed: 25853989
Psychoneuroendocrinology. 2014 Aug;46:141-52
pubmed: 24882166
Psychiatry Res. 2018 Feb;260:111-115
pubmed: 29179015
Eur Respir J. 2015 Mar;45(3):790-806
pubmed: 25614163
J Complement Integr Med. 2019 Aug 15;17(1):
pubmed: 31421042
Exp Gerontol. 2003 Jun;38(6):669-72
pubmed: 12814802
Physiology (Bethesda). 2020 Mar 1;35(2):112-124
pubmed: 32027562
J Allergy Clin Immunol. 2011 Mar;127(3):701-21.e1-70
pubmed: 21377040
Hum Psychopharmacol. 2004 Aug;19(6):397-403
pubmed: 15303243
Z Kinder Jugendpsychiatr Psychother. 2016;44(2):113-26
pubmed: 27008901
Nature. 2013 Jan 31;493(7434):674-8
pubmed: 23254930
Cytokine. 2015 Jul;74(1):27-34
pubmed: 25481648
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:277-84
pubmed: 26111720
Mediators Inflamm. 2018 Mar 8;2018:6039171
pubmed: 29706800
Molecules. 2021 Apr 19;26(8):
pubmed: 33921721
Nutrients. 2016 Jun 02;8(6):
pubmed: 27271660
J Pharm Pharm Sci. 2007;10(4):554-66
pubmed: 18261375
Front Psychol. 2020 Aug 19;11:1763
pubmed: 32973596
World J Biol Psychiatry. 2020 Oct;21(8):634-641
pubmed: 31552779
J Affect Disord. 2022 Aug 15;311:344-352
pubmed: 35561887
Cytokine Growth Factor Rev. 2001 Mar;12(1):53-72
pubmed: 11312119
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):760-8
pubmed: 20600462
Front Immunol. 2019 Jul 19;10:1696
pubmed: 31379879
J Pathol. 2008 Jan;214(2):149-60
pubmed: 18161752
J Inflamm (Lond). 2018 Nov 16;15:23
pubmed: 30473634
Brain Behav Immun. 2020 Aug;88:631-639
pubmed: 32380271
Medicine (Baltimore). 2019 Jan;98(4):e13955
pubmed: 30681555
Int J Neurosci. 2017 Jul;127(7):624-633
pubmed: 27412492
Front Immunol. 2018 Apr 09;9:586
pubmed: 29686666
J Alzheimers Dis. 2011;25(2):279-93
pubmed: 21403390
Inflamm Allergy Drug Targets. 2009 Sep;8(4):266-76
pubmed: 19754410
J Mol Med (Berl). 2021 Nov;99(11):1553-1569
pubmed: 34432073
J Inflamm Res. 2018 Dec 20;12:1-14
pubmed: 30588059
Biomedicines. 2021 Nov 04;9(11):
pubmed: 34829842
Free Radic Biol Med. 2018 Feb 1;115:80-91
pubmed: 29080843
Lancet Psychiatry. 2019 Feb;6(2):164-173
pubmed: 30366684
J Neurochem. 2016 Oct;139 Suppl 2:136-153
pubmed: 26990767
BMC Neurosci. 2011 Dec 01;12:123
pubmed: 22133203
J Psychiatr Res. 2013 Mar;47(3):401-6
pubmed: 23290488
Mediators Inflamm. 2004 Jun;13(3):205-7
pubmed: 15223613
Front Immunol. 2019 Jul 04;10:1525
pubmed: 31333659
Immunol Rev. 2015 May;265(1):6-21
pubmed: 25879280
Eur J Immunol. 2016 Feb;46(2):269-80
pubmed: 26626159
CNS Neurol Disord Drug Targets. 2016;15(4):414-33
pubmed: 26996176
J Integr Neurosci. 2021 Sep 30;20(3):765-776
pubmed: 34645110
Turk J Phys Med Rehabil. 2021 Sep 01;67(3):344-350
pubmed: 34870122
Nat Rev Immunol. 2017 Jan;17(1):49-59
pubmed: 27916979
Int J Environ Res Public Health. 2021 Jun 22;18(13):
pubmed: 34206284
Psychoneuroendocrinology. 2012 Sep;37(9):1521-30
pubmed: 22406002
Mech Ageing Dev. 2006 Jun;127(6):526-37
pubmed: 16530252
J Neuroinflammation. 2021 Nov 27;18(1):276
pubmed: 34838047
Int J Ment Health Addict. 2021 Jun 10;:1-17
pubmed: 34131416
Semin Cancer Biol. 2016 Jun;37-38:26-35
pubmed: 26773346
Front Immunol. 2018 Jun 07;9:1302
pubmed: 29951057
FASEB J. 2017 Feb;31(2):701-710
pubmed: 27811060
Metab Brain Dis. 2009 Mar;24(1):27-53
pubmed: 19085093